About this trial
This study is a single-center, randomized, open-label, controlled, endpoint-blinded study to assess the effect of off-script diagnosis \& differential diagnosis (D\&D) training in improving the residents' knowledge of acute ischemic stroke in China. The investigators will enroll 22 residents and assess the score of mASMaQ 30 days after randomization.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Residents (physicians in postgraduate training).
Currently in neurology wards
Managing acute ischemic stroke (AIS) patients, defined as: 1)Time from onset to randomization ≤ 2 weeks; 2) If onset time is unknown, the last known well time is considered the onset time.
Signed informed consent
Disqualifiers
Managing asymptomatic ischemic stroke patients.
Residents who are currently participating or have participated in another interventional ischemic stroke training program within the past 3 months.
Trial design
Parallel
Treatments tested in this trial
Off-script diagnosis & differential diagnosis (D&D) training
Other intervention1. Training Timeline: Must be completed within 72 hours post-randomization; Requires standardized structured off-script D\&D analysis. 2. Structured Analysis Framework: 1)Epidemiology: Incidence, mortality, and disability rates; 2) Etiologic Classification: TOAST classification system; 3) Vascular Mechanisms: Culprit vessel, vascular territory, pathophysiology; 4) Differential Diagnosis: Stroke mimics and stroke subtype differentiation; 5) Acute Management: Hyperacute interventions (thrombolysis/EVT), secondary prevention strategies, and evidence-based case analysis; 6) Patient Education: Stroke prevention education for patients/public; 7) Research Gaps: Current limitations and future directions. 3. Presentation Requirements: 1)Mandatory off-script delivery (no prepared text); 2) Time limit: 15+3 minutes for complete analysis.
Treatment groups
Trial outcomes
Primary outcomes
mASMaQ
Modified Acute Stroke Management Questionnaire (mASMaQ), with a range of 33-165 scores. Higher scores indicate superior acute ischemic stroke management knowledge. Blinded Assessment Protocol:1) Participant Requirements: Strict 10-minute time limit for independent completion; External references are prohibited; 2) Assessment Supervision: certified neurologists as proctors, who are blinded to group assignment throughout the trial. 3) Centralized Adjudication: based on participants' questionnaire responses. Note: Details of the modified ASMaQ has been on file with the ethics committee and cannot be changed. To prevent disclosure of the measures and bias in resident measurement, we do not disclose the scales until the trial is completed. Details of mASMaQ will be made public with the publication of the article.
Secondary outcomes
General stroke knowledge
Part of mASMaQ, with a range of 10-50. Higher scores indicate superior general stroke knowledge.
Hyperacute stroke management
Part of mASMaQ, with a range of 9-45. Higher scores indicate superior hyperacute stroke management knowledge.
Advanced stroke management
Part of mASMaQ, with a range of 14-70. Higher scores indicate superior advanced stroke management knowledge.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.